Regulatory Compliance for South East Asia

Maytal is excited to share an important strategic development in our March 2026 newsletter: we are actively exploring expanded opportunities in regulatory compliance for medical devices and in vitro diagnostics (IVD) across Southeast Asia.

As a trusted partner with over 20 years of expertise in navigating complex regulatory landscapes — from CE marking under the EU MDR/IVDR, UKCA in the United Kingdom, FDA 510(k) submissions in the United States, to Health Canada requirements — Maytal has built a strong foundation supporting manufacturers in achieving compliant market access in established regions. Our services include full technical documentation, risk management (ISO 14971), clinical evaluations, quality management systems (ISO 13485, MDSAP), validation processes, and ongoing post-market support.

Why Southeast Asia Now?

The Southeast Asian medical device market is experiencing rapid growth, driven by increasing healthcare investments, aging populations, rising demand for advanced diagnostics and therapeutic devices, and ongoing efforts toward regional harmonization. Key highlights include:

The ASEAN Medical Device Directive (AMDD) continues to promote greater alignment across member states (including Singapore, Malaysia, Indonesia, Thailand, Vietnam, Philippines, and others), with tools like the Common Submission Dossier Template (CSDT) and risk-based classification systems simplifying multi-country strategies.

Recent regulatory advancements — such as reliance pilots between Malaysia-Singapore (launched in 2025) and similar initiatives with Thailand — are reducing review times, minimizing duplication, and accelerating approvals for devices already cleared in reference markets.

Countries like Singapore (via HSA) serve as strategic gateways, often acting as benchmarks for reliance pathways in neighboring markets, while Malaysia and Thailand strengthen local manufacturing and export capabilities.

These developments create exciting possibilities for international manufacturers seeking efficient entry into one of the world's fastest-growing regions. With harmonization momentum and streamlined processes, companies can achieve broader market access with smarter, more cost-effective compliance approaches.

Maytal's Next Steps

We are proactively deepening our knowledge of local requirements, building strategic partnerships, and preparing tailored support packages for clients interested in Southeast Asian expansion. Whether you're a startup developing innovative devices, an established manufacturer looking to diversify beyond Europe and North America, or a company facing multi-country registration challenges, Maytal is positioning itself to guide you through:

• ASEAN-specific dossier preparation and submissions

• Leveraging reference approvals for faster pathways

• Compliance with national variations while maximizing harmonized elements

If this aligns with your growth plans, we invite you to reach out. Our team is ready to discuss how we can support your Southeast Asian ambitions — from initial regulatory assessments to full registration strategies.

Stay tuned for more updates as we progress in this dynamic region. We're committed to helping our clients bring safe, innovative medical technologies to patients worldwide.